Aurobindo Pharma Ltd. | AUROPHARMA | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
150,899164,998195,636230,985247,746
Cost of revenue
Cost of revenue
-64,343-67,527-87,126-97,352-99,025
Gross Profit
Gross Profit
86,556
97,471
108,509
133,633
148,722
Sales, general & ad...
Sales, general and administrative
-52,213-59,753-68,990-84,990-95,387
Depreciation
Depreciation and amortization
-4,276-5,580-6,680-9,667-10,554
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
30,067
32,138
32,840
38,976
42,780
 
      
Interest expense
Interest expense
-667-777-2,626-3,051-745
Other income/exp...
Other income(expense)
1,1591,0206731,65731,954
Profit before tax
Profit before tax
30,558
32,380
30,887
37,582
73,990
Income tax & other ta...
Income tax and other taxes
7,5978,1837,2699,13520,098
Net income from c...
Net income from continuing operations
22,96224,19823,61828,44753,892
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00000
Share of associates
Share of associates
503127-152-554
Minority Interest
Minority Interest
50015-10
Net Income
Net income
23,017
24,229
23,645
28,310
53,328
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
23,01724,22923,64528,31053,328
Basic shares
Basic shares
585586586586586
Diluted Shares
Diluted Shares
585586586586586
EPS Basic
EPS Basic in Rupees
39.3341.3540.3648.3291.01
EPS Diluted
EPS Diluted in Rupees
39.33
41.35
40.35
48.32
91.01